By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Johnson & Johnson 

1 Johnson & Johnson Plaza

New Brunswick  New Jersey  08933  U.S.A.
Phone: 732-524-0400 Fax: 732-524-3300




Alliance Pharmaceutical Corp.  Oxygent ™ co-development

Medarex, Inc.  Broad HuMAb-Mouse antibody development agreement.

Genetronics, Inc.  On October 6, 1998 Genetronics entered into comprehensive development and license agreements involving its proprietary drug delivery system for Electroporation Therapy treatment of cancer with Ethicon, Inc., a Johnson & Johnson company

Essential Therapeutics, Inc.   Cephalosporin which is currently in pre-clinical stages - and will target Staphylococcal infections, Enterococcal infections, and Streptococcus pneumoniae infections.

Pharmagene Laboratories Limited 

Amersham Biosciences 

Bristol-Myers Squibb 

PanVera LLC 


Massachusetts Life Sciences Center 

Company News
In a Busy Year, TRACON Pharma (TCON) Inks $182.5 Million Oncology Deal With Johnson & Johnson (JNJ) 9/28/2016 6:15:15 AM
Johnson & Johnson (JNJ) Advances Commitment To Improve Global Health And Well-Being 9/22/2016 10:07:35 AM
How Johnson & Johnson (JNJ) and Google (GOOG) Plan to Build a Better Robot 9/22/2016 8:08:23 AM
How Abbott (ABT)'s Eye Deal With Johnson & Johnson (JNJ) Isn't About Alere (ALR) 9/20/2016 7:04:12 AM
FDA Places Clinical Hold on AML Drug Co-Developed by Johnson & Johnson (JNJ) and Genmab A/S (GEN.CO) 9/19/2016 8:23:35 AM
Johnson & Johnson (JNJ) Buying 100 Megawatts Of Texas Wind Power 9/19/2016 7:41:17 AM
M&A Bonanza Continues as Johnson & Johnson (JNJ) Pays $4.325 Billion for Abbott (ABT)'s Eye Surgery Biz 9/16/2016 2:49:51 PM
Johnson & Johnson (JNJ) Announces WHO Will Review Ebola Vaccine Regimen For Emergency Use Assessment And Listing (EUAL) 9/13/2016 9:14:20 AM
Gilead (GILD) Looks Over Shoulder as Johnson & Johnson (JNJ) Eyes Taking a Bite Out of Hep C Market 9/12/2016 6:14:02 AM
Achillion (ACHN), Johnson & Johnson (JNJ)'s Hep C Candidate Scores a 100% Cure Rate in Phase IIa Trial 9/9/2016 5:46:17 AM